Benzinga
España
Italia
대한민국
日本
Français
My Account
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Benzinga
Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
Events Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Options Profit Calculator
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Covered Call Calculator
Cash-Secured Put Calculator
Long Call Calculator
Long Put Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
Health Care
Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock Soars
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Johnson & Johnson Finds Growth Beyond Legacy Drugs, Lifts 2026 Outlook
Nextcure Transforms Into Avere as Investors Back Oral Psoriasis Therapy
Johnson & Johnson Finds Growth Beyond Legacy Drugs, Lifts 2026 Outlook
Nextcure Transforms Into Avere as Investors Back Oral Psoriasis Therapy
Why Is Biogen Stock Falling Tuesday?
Silo Pharma Unit Eyes Faster AI Agent Development Through AMD Partnership
Read More...
Health Care Recent News
AtaiBeckley (ATAI) Stock Skyrockets 65% After-Hours on Reported Eli Lilly Acquisition Talks (CORRECTED)
AtaiBeckley shares jumped 64.70% after hours following reports that Eli Lilly is in talks to acquire the psychedelic drugmaker at a premium.
Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug
Novo Nordisk wins EU approval for Wegovy pill, the first oral GLP-1 for weight management, backed by OASIS trial data.
Ernexa Therapeutics Stock Climbs After Independent Study Validates ERNA-101 Tumor-Fighting Cell Therapy
Ernexa Therapeutics reports independent preclinical validation of ERNA-101 with PD-1 therapy ahead of the planned 2026 IND filing.
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months
Veradermics reported positive phase 2 data for VDPHL01, showing hair growth and favorable safety in women with pattern hair loss.
FTC Says CVS Caremark Settlement Could Save Consumers Upto $13 Billion
FTC settlement with CVS Caremark targets rebate practices, pharmacy access and transparency, with potential consumer savings of up to $13 billion.
Catheter Precision (VTAK) Stock Surges Over 19% After Hours: Why is it Moving?
Catheter Precision Inc. shares jumped 19.36% after hours as investors reacted to a filing registering resale of 68.06 million common shares.
Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session
Glucotrack Inc. shares jumped 69.27% after hours as investors reacted to the company's newly allowed U.S. patent for its glucose monitoring.
Erasca Unveils Updated Cancer Candidate Progress, Maps Path Toward Pivotal Cancer Trials
Erasca reported updated Phase 1 ERAS-0015 data, outlined pivotal trial plans and priced an upsized $550 million stock offering.
Why Is Agenus Stock Falling on Tuesday?
Agenus Inc. (AGEN) stock experiences profit-taking on Tuesday after a 111% surge. Discover the latest clinical data and analyst updates.
HCA Healthcare Trims 2026 Profit Outlook, Stock Falls
HCA Healthcare's preliminary Q2 results showed higher revenue and EPS despite a $400 million hit from a shift toward uninsured patients.
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results
Envoy Medical reported improved 12-month hearing results for its Acclaim cochlear implant as its pivotal trial advances toward FDA filing.
Trump Admin Rescinds $10 Billion Child Care Funding Freeze for Five Democratic-Led States
The funding freeze on child care subsidies and social services has been lifted by the U.S. Department of Health and Human Services.
New Bipartisan Bill Wants To End Daylight Saving Time Clock Changes — But Not The Way You'd Think
A bipartisan bill would make standard time permanent while allowing states to adopt year-round daylight saving time.
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started